Industry: Medical Devices & Consumables
Published Date: 2025-08-01
Pages: 79 Pages
Report ld: 4830142
Request Sample
Customized Report
The global Medical Automated Compounding Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Medical Automated Compounding Systems market competitiveness, regional economic performance, and supply chain configurations.
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
The North America Medical Automated Compounding Systems market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Medical Automated Compounding Systems include Baxter, Comecer, ICU Medical, Omnicell, Grifols, EQUASHIELD, B. Braun, ARxIUM, NewIcon, Steriline, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Medical Automated Compounding Systems market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Medical Automated Compounding Systems market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Semi-automatic in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Drugstore in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Medical Automated Compounding Systems value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Medical Automated Compounding Systems Product Scope
1.2 Medical Automated Compounding Systems by Type
1.2.1 Global Medical Automated Compounding Systems Sales by Type (2020 & 2024 & 2031)
1.2.2 Fully-automatic
1.2.3 Semi-automatic
1.3 Medical Automated Compounding Systems by Application
1.3.1 Global Medical Automated Compounding Systems Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Others
1.4 Global Medical Automated Compounding Systems Market Estimates and Forecasts (2020-2031)
1.4.1 Global Medical Automated Compounding Systems Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Medical Automated Compounding Systems Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Medical Automated Compounding Systems Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Medical Automated Compounding Systems Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Medical Automated Compounding Systems Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Medical Automated Compounding Systems Sales Market Share by Region (2020-2025)
2.2.2 Global Medical Automated Compounding Systems Revenue Market Share by Region (2020-2025)
2.3 Global Medical Automated Compounding Systems Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Medical Automated Compounding Systems Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Medical Automated Compounding Systems Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Medical Automated Compounding Systems Market Size and Prospective (2020-2031)
2.4.2 Europe Medical Automated Compounding Systems Market Size and Prospective (2020-2031)
2.4.3 China Medical Automated Compounding Systems Market Size and Prospective (2020-2031)
2.4.4 Japan Medical Automated Compounding Systems Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Medical Automated Compounding Systems Historic Market Review by Type (2020-2025)
3.1.1 Global Medical Automated Compounding Systems Sales by Type (2020-2025)
3.1.2 Global Medical Automated Compounding Systems Revenue by Type (2020-2025)
3.1.3 Global Medical Automated Compounding Systems Price by Type (2020-2025)
3.2 Global Medical Automated Compounding Systems Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Medical Automated Compounding Systems Sales Forecast by Type (2026-2031)
3.2.2 Global Medical Automated Compounding Systems Revenue Forecast by Type (2026-2031)
3.2.3 Global Medical Automated Compounding Systems Price Forecast by Type (2026-2031)
3.3 Different Types Medical Automated Compounding Systems Representative Players
4 Global Market Size by Application
4.1 Global Medical Automated Compounding Systems Historic Market Review by Application (2020-2025)
4.1.1 Global Medical Automated Compounding Systems Sales by Application (2020-2025)
4.1.2 Global Medical Automated Compounding Systems Revenue by Application (2020-2025)
4.1.3 Global Medical Automated Compounding Systems Price by Application (2020-2025)
4.2 Global Medical Automated Compounding Systems Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Medical Automated Compounding Systems Sales Forecast by Application (2026-2031)
4.2.2 Global Medical Automated Compounding Systems Revenue Forecast by Application (2026-2031)
4.2.3 Global Medical Automated Compounding Systems Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Medical Automated Compounding Systems Application
5 Competition Landscape by Players
5.1 Global Medical Automated Compounding Systems Sales by Players (2020-2025)
5.2 Global Top Medical Automated Compounding Systems Players by Revenue (2020-2025)
5.3 Global Medical Automated Compounding Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Automated Compounding Systems as of 2024)
5.4 Global Medical Automated Compounding Systems Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Medical Automated Compounding Systems, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Medical Automated Compounding Systems, Product Type & Application
5.7 Global Key Manufacturers of Medical Automated Compounding Systems, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Medical Automated Compounding Systems Sales by Company
6.1.1.1 North America Medical Automated Compounding Systems Sales by Company (2020-2025)
6.1.1.2 North America Medical Automated Compounding Systems Revenue by Company (2020-2025)
6.1.2 North America Medical Automated Compounding Systems Sales Breakdown by Type (2020-2025)
6.1.3 North America Medical Automated Compounding Systems Sales Breakdown by Application (2020-2025)
6.1.4 North America Medical Automated Compounding Systems Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Medical Automated Compounding Systems Sales by Company
6.2.1.1 Europe Medical Automated Compounding Systems Sales by Company (2020-2025)
6.2.1.2 Europe Medical Automated Compounding Systems Revenue by Company (2020-2025)
6.2.2 Europe Medical Automated Compounding Systems Sales Breakdown by Type (2020-2025)
6.2.3 Europe Medical Automated Compounding Systems Sales Breakdown by Application (2020-2025)
6.2.4 Europe Medical Automated Compounding Systems Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Medical Automated Compounding Systems Sales by Company
6.3.1.1 China Medical Automated Compounding Systems Sales by Company (2020-2025)
6.3.1.2 China Medical Automated Compounding Systems Revenue by Company (2020-2025)
6.3.2 China Medical Automated Compounding Systems Sales Breakdown by Type (2020-2025)
6.3.3 China Medical Automated Compounding Systems Sales Breakdown by Application (2020-2025)
6.3.4 China Medical Automated Compounding Systems Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Medical Automated Compounding Systems Sales by Company
6.4.1.1 Japan Medical Automated Compounding Systems Sales by Company (2020-2025)
6.4.1.2 Japan Medical Automated Compounding Systems Revenue by Company (2020-2025)
6.4.2 Japan Medical Automated Compounding Systems Sales Breakdown by Type (2020-2025)
6.4.3 Japan Medical Automated Compounding Systems Sales Breakdown by Application (2020-2025)
6.4.4 Japan Medical Automated Compounding Systems Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Business Overview
7.1.3 Baxter Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Baxter Medical Automated Compounding Systems Products Offered
7.1.5 Baxter Recent Development
7.2 Comecer
7.2.1 Comecer Company Information
7.2.2 Comecer Business Overview
7.2.3 Comecer Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Comecer Medical Automated Compounding Systems Products Offered
7.2.5 Comecer Recent Development
7.3 ICU Medical
7.3.1 ICU Medical Company Information
7.3.2 ICU Medical Business Overview
7.3.3 ICU Medical Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.3.4 ICU Medical Medical Automated Compounding Systems Products Offered
7.3.5 ICU Medical Recent Development
7.4 Omnicell
7.4.1 Omnicell Company Information
7.4.2 Omnicell Business Overview
7.4.3 Omnicell Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Omnicell Medical Automated Compounding Systems Products Offered
7.4.5 Omnicell Recent Development
7.5 Grifols
7.5.1 Grifols Company Information
7.5.2 Grifols Business Overview
7.5.3 Grifols Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Grifols Medical Automated Compounding Systems Products Offered
7.5.5 Grifols Recent Development
7.6 EQUASHIELD
7.6.1 EQUASHIELD Company Information
7.6.2 EQUASHIELD Business Overview
7.6.3 EQUASHIELD Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.6.4 EQUASHIELD Medical Automated Compounding Systems Products Offered
7.6.5 EQUASHIELD Recent Development
7.7 B. Braun
7.7.1 B. Braun Company Information
7.7.2 B. Braun Business Overview
7.7.3 B. Braun Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.7.4 B. Braun Medical Automated Compounding Systems Products Offered
7.7.5 B. Braun Recent Development
7.8 ARxIUM
7.8.1 ARxIUM Company Information
7.8.2 ARxIUM Business Overview
7.8.3 ARxIUM Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.8.4 ARxIUM Medical Automated Compounding Systems Products Offered
7.8.5 ARxIUM Recent Development
7.9 NewIcon
7.9.1 NewIcon Company Information
7.9.2 NewIcon Business Overview
7.9.3 NewIcon Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.9.4 NewIcon Medical Automated Compounding Systems Products Offered
7.9.5 NewIcon Recent Development
7.10 Steriline
7.10.1 Steriline Company Information
7.10.2 Steriline Business Overview
7.10.3 Steriline Medical Automated Compounding Systems Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Steriline Medical Automated Compounding Systems Products Offered
7.10.5 Steriline Recent Development
8 Medical Automated Compounding Systems Manufacturing Cost Analysis
8.1 Medical Automated Compounding Systems Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Medical Automated Compounding Systems
8.4 Medical Automated Compounding Systems Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Medical Automated Compounding Systems Distributors List
9.3 Medical Automated Compounding Systems Customers
10 Medical Automated Compounding Systems Market Dynamics
10.1 Medical Automated Compounding Systems Industry Trends
10.2 Medical Automated Compounding Systems Market Drivers
10.3 Medical Automated Compounding Systems Market Challenges
10.4 Medical Automated Compounding Systems Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Medical Automated Compounding Systems market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 145
USD 4900.00
(Single User License)
The global Medical Automated Compounding Systems market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 79
USD 4250.00
(Single User License)
The global market for Medical Automated Compounding Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 105
USD 3950.00
(Single User License)
The global Medical Automated Compounding Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 108
USD 2900.00
(Single User License)
The global Medical Automated Compounding Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 131
USD 4900.00
(Single User License)
The global market for Medical Automated Compounding Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 109
USD 3950.00
(Single User License)
The global market for Medical Automated Compounding Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 84
USD 2900.00
(Single User License)
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
Published Date: 2024-05-27
Pages: 103
USD 3950.00
(Single User License)
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
Published Date: 2024-05-27
Pages: 129
USD 4900.00
(Single User License)
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
Published Date: 2024-05-27
Pages: 107
USD 4350.00
(Single User License)
The global Medical Automated Compounding Systems market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 145
The global Medical Automated Compounding Systems market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 79
The global market for Medical Automated Compounding Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 105
The global Medical Automated Compounding Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 108
The global Medical Automated Compounding Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 131
The global market for Medical Automated Compounding Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 109
The global market for Medical Automated Compounding Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 84
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
Published: 2024-05-27
Pages: 103
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
Published: 2024-05-27
Pages: 129
An Medical Automated Compounding System (MACS) is a technology-driven system used in healthcare settings, particularly in pharmacies and hospitals, to accurately and efficiently prepare sterile intravenous (IV) medications. These systems automate the process of compounding medications, which involves measuring, mixing, and packaging prescribed doses of medications for patients, especially for those who require customized doses or have specific medication needs that cannot be met by commercially available products.
Published: 2024-05-27
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now